GLP-1s are being studied for a wide range of conditions. Now, scientists will test whether their anti-inflammatory properties ...

And even well-insured patients receive unaffordable bills in this era of high-deductible health plans, narrow insurance ...

As health care companies grow larger, so are patient costs but federal regulators have been slow to confront the issue during the Trump administration. A cancer patient might live in a town with four ...

GLP-1 drugs like tirzepatide and semaglutide offer powerful weight-loss effects but come with unanswered questions about long ...

Q: I’m only 45, but my doctor says that I need to focus on my heart health — make sure my cholesterol level remains healthy ...

Pfizer beats Q3 estimates, raises FY guidance, acquires Metsera for obesity drugs, and offers a 7% yield. Read here for an ...

Pfizer’s respiratory syncytial virus vaccine was more than 90% effective among older adults during the first season it was available, including among those with underlying conditions or severe disease ...

A new pill from Merck could change how millions of people treat high cholesterol and help prevent heart attacks and strokes ...

Eli Lilly has made the decision to discontinue manufacturing its migraine therapy Reyvow (lasmiditan), according to the FDA’s Drug Shortages tracker.

Makhana has been part of Bihar's culture and traditions for a long time. It is a popular healthy snack, all thanks to its ...

Clinicians must adapt to the new reality of HFMD, as emerging strains drive serious complications and challenge old ...

In TUXEDO-2, ticagrelor failed to meet the bar for noninferiority, with most outcomes hinting at an advantage for prasugrel.